These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 26400345)

  • 21. Overexpression of BST2 is associated with nodal metastasis and poorer prognosis in oral cavity cancer.
    Fang KH; Kao HK; Chi LM; Liang Y; Liu SC; Hseuh C; Liao CT; Yen TC; Yu JS; Chang KP
    Laryngoscope; 2014 Sep; 124(9):E354-60. PubMed ID: 24706327
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical Implications of FADD Gene Amplification and Protein Overexpression in Taiwanese Oral Cavity Squamous Cell Carcinomas.
    Chien HT; Cheng SD; Chuang WY; Liao CT; Wang HM; Huang SF
    PLoS One; 2016; 11(10):e0164870. PubMed ID: 27764170
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nuclear heterogeneous nuclear ribonucleoprotein D is associated with poor prognosis and interactome analysis reveals its novel binding partners in oral cancer.
    Kumar M; Matta A; Masui O; Srivastava G; Kaur J; Thakar A; Shukla NK; RoyChoudhury A; Sharma M; Walfish PG; Michael Siu KW; Chauhan SS; Ralhan R
    J Transl Med; 2015 Aug; 13():285. PubMed ID: 26318153
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Correlation of increased twist with lymph node metastasis in patients with oral squamous cell carcinoma.
    Wushou A; Pan HY; Liu W; Tian Z; Wang LZ; Shali S; Zhang ZY
    J Oral Maxillofac Surg; 2012 Jun; 70(6):1473-9. PubMed ID: 21864967
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Up-regulation of survivin in oral squamous cell carcinoma correlates with poor prognosis and chemoresistance.
    Su L; Wang Y; Xiao M; Lin Y; Yu L
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Oct; 110(4):484-91. PubMed ID: 20868995
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of vascular endothelial growth factor is significantly associated with progression and prognosis of oral squamous cell carcinomas in Taiwan.
    Cheng SJ; Lee JJ; Kok SH; Chou CH; Chang HH; Yang H; Chiang ML; Kuo MY
    J Formos Med Assoc; 2011 Jan; 110(1):50-7. PubMed ID: 21316013
    [TBL] [Abstract][Full Text] [Related]  

  • 27. ASC contributes to metastasis of oral cavity squamous cell carcinoma.
    Wu CS; Chang KP; OuYang CN; Kao HK; Hsueh C; Chen LC; Cheng HY; Liang Y; Liou W; Liang CL; Chang YS
    Oncotarget; 2016 Aug; 7(31):50074-50085. PubMed ID: 27367024
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Loss of NKX3-1 as a potential marker for an increased risk of occult lymph node metastasis and poor prognosis in oral squamous cell carcinoma.
    Miyaguchi K; Uzawa N; Mogushi K; Takahashi K; Michikawa C; Nakata Y; Sumino J; Okada N; Mizushima H; Fukuoka Y; Tanaka H
    Int J Oncol; 2012 Jun; 40(6):1907-14. PubMed ID: 22344708
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of vascular endothelial growth factor-C does not predict occult lymph-node metastasis in early oral squamous cell carcinoma.
    Faustino SE; Oliveira DT; Nonogaki S; Landman G; Carvalho AL; Kowalski LP
    Int J Oral Maxillofac Surg; 2008 Apr; 37(4):372-8. PubMed ID: 18295452
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Keratins 17 and 19 expression as prognostic markers in oral squamous cell carcinoma.
    Coelho BA; Peterle GT; Santos M; Agostini LP; Maia LL; Stur E; Silva CV; Mendes SO; Almança CC; Freitas FV; Borçoi AR; Archanjo AB; Mercante AM; Nunes FD; Carvalho MB; Tajara EH; Louro ID; Silva-Conforti AM
    Genet Mol Res; 2015 Nov; 14(4):15123-32. PubMed ID: 26634475
    [TBL] [Abstract][Full Text] [Related]  

  • 31. FKBP51 Immunohistochemical Expression: A New Prognostic Biomarker for OSCC?
    Russo D; Merolla F; Mascolo M; Ilardi G; Romano S; Varricchio S; Napolitano V; Celetti A; Postiglione L; Di Lorenzo PP; Califano L; Dell'Aversana GO; Astarita F; Romano MF; Staibano S
    Int J Mol Sci; 2017 Feb; 18(2):. PubMed ID: 28218707
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tumor expression of miR-448 is a prognostic marker in oral squamous cell carcinoma.
    Wei H; Yu K; Liu Y; Li L; Wang G
    BMC Cancer; 2020 Aug; 20(1):756. PubMed ID: 32787801
    [TBL] [Abstract][Full Text] [Related]  

  • 33. KiSS-1 expression in oral squamous cell carcinoma and its prognostic significance.
    Shin WJ; Cho YA; Kang KR; Kim JH; Hong SD; Lee JI; Hong SP; Yoon HJ
    APMIS; 2016 Apr; 124(4):291-8. PubMed ID: 26809635
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic significance of Fas and Fas ligand expressions in human esophageal cancer.
    Shibakita M; Tachibana M; Dhar DK; Kotoh T; Kinugasa S; Kubota H; Masunaga R; Nagasue N
    Clin Cancer Res; 1999 Sep; 5(9):2464-9. PubMed ID: 10499620
    [TBL] [Abstract][Full Text] [Related]  

  • 35. P-cadherin expression and survival rate in oral squamous cell carcinoma: an immunohistochemical study.
    Lo Muzio L; Campisi G; Farina A; Rubini C; Pannone G; Serpico R; Laino G; De Lillo A; Carinci F
    BMC Cancer; 2005 Jun; 5():63. PubMed ID: 15967043
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increased Cdc7 expression is a marker of oral squamous cell carcinoma and overexpression of Cdc7 contributes to the resistance to DNA-damaging agents.
    Cheng AN; Jiang SS; Fan CC; Lo YK; Kuo CY; Chen CH; Liu YL; Lee CC; Chen WS; Huang TS; Wang TY; Lee AY
    Cancer Lett; 2013 Sep; 337(2):218-25. PubMed ID: 23684929
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of Bcl-2 family proteins and associated clinicopathologic factors predict survival outcome in patients with oral squamous cell carcinoma.
    Camisasca DR; Honorato J; Bernardo V; da Silva LE; da Fonseca EC; de Faria PA; Dias FL; Lourenço Sde Q
    Oral Oncol; 2009 Mar; 45(3):225-33. PubMed ID: 18715811
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cyclin D1 gene numerical aberration is a predictive marker for occult cervical lymph node metastasis in TNM Stage I and II squamous cell carcinoma of the oral cavity.
    Myo K; Uzawa N; Miyamoto R; Sonoda I; Yuki Y; Amagasa T
    Cancer; 2005 Dec; 104(12):2709-16. PubMed ID: 16265665
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prediction of outcome of patients with oral squamous cell carcinoma using vascular invasion and the strongly positive expression of vascular endothelial growth factors.
    Seki S; Fujiwara M; Matsuura M; Fujita S; Ikeda H; Asahina I; Ikeda T
    Oral Oncol; 2011 Jul; 47(7):588-93. PubMed ID: 21602095
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of survivin as a prognostic marker in oral squamous cell carcinoma.
    Kim YH; Kim SM; Kim YK; Hong SP; Kim MJ; Myoung H
    J Oral Pathol Med; 2010 May; 39(5):368-75. PubMed ID: 20050981
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.